Rezolute Inc

Research Rezolute Inc (RZLT) on Bullrun: market cap USD 491.09M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerRZLT
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 491.09M
• Financial periodFY2025
• Net income-USD 74.40M

Valuation Snapshot

latest market cap is USD 491.09M.

About Rezolute Inc

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism.

Frequently asked questions

What is Rezolute Inc's market cap?

Rezolute Inc's market capitalization is USD 491.09M.

What does Rezolute Inc do?

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.